International Scholarly Research Notices / 2012 / Article / Tab 1 / Clinical Study
Impact of Dual Antiplatelet Therapy with Proton Pump Inhibitors on the Outcome of Patients with Acute Coronary Syndrome Undergoing Drug-Eluting Stent Implantation Table 1 Population characteristics.
Total (
š
=
1
7
6
) PPI group (
š
=
1
2
1
) Anti-H2 group (
š
=
5
5
)
š
value < 0.05Demographics characteristics āAge
6
4
.
3
1
Ā±
1
0
.
0
8
6
3
.
6
6
Ā±
1
0
.
5
6
6
5
.
7
5
Ā±
8
.
8
5
0.203 āMale
š
(%) 145 (82.38) 97 (80.16) 48 (87.27) 0.196 Clinical characteristics
š
(%) āSmoke 61 (34.65) 45 (37.19) 15 (27.27) 0.265 āDyslipidemia 97 (55.11) 65 (53.71) 32 (58.18) 0.697 āFamiliar history 63 (35.79) 42 (34.71) 21 (38.18) 0.782 āHypertension 130 (73.86) 85 (70.24) 45 (81.81) 0.152 āObesity (
B
M
I
>
3
0
Kg/m2 ) 22 (12.50) 11 (9.09) 11 (20) 0.074 āDiabetes 78 (44.31) 50 (41.32) 33 (49.09) 0.43 āPrevious CABG 11 (6.25) 11 (9.09) 0 (0) 0.048 āPrevious AF 5 (2.84) 1 (0.82) 4 (7.27) 0.057 āPrevious AMI 28 (15.90) 20 (16.52) 8 (14.54) 0.912 āPrevious PCI 38 (21.59) 29 (23.96) 9 (16.36) 0.348 āPrevious HF 4 (2.27) 3 (2.47) 1 (1.81) 0.784 āRenal failure 38 (21.59) 28 (23.14) 10 (18.18) 0.587 āAnemia
š
(%) 62 (35.22) 50 (41.32) 12 (21.81) 0.019 Therapy at discharge
š
(%) āACE inhibitors 106 (60.22) 75 (61.98) 30 (54.54) 0.443 ā
š½
-blockers 137 (77.84) 94 (77.68) 43 (78.18) 0.903 āStatine 163 (92.61) 109 (90.08) 54 (98.18) 0.111 Angiographics data āMultivessel disease
š
(%) 64 (36.36) 44 (36.36) 20 (36.36) 0.865 āNo. of stents 1.26 Ā± 0.56 1.24 Ā± 0.60 1.25 Ā± 0.55 0.916
CABG: coronary artery bypass graft surgery; AF: atrial fibrillation; HF: heart failure; AMI: acute myocardial infarction; PCI: percutaneous coronary intervention.
